Related Experiment Videos
Directed evolution of a stable scaffold for T-cell receptor engineering
E V Shusta1, P D Holler, M C Kieke
1Department of Chemical Engineering, University of Illinois, Urbana, IL 61801, USA.
Nature Biotechnology
|July 11, 2000
Summary
Researchers engineered a stable single-chain T-cell receptor (scTCR) scaffold using directed evolution. This breakthrough enhances scTCRs for potential use as antagonists in cell-mediated immunity therapies.
Area of Science:
- Immunology
- Protein Engineering
- Biotechnology
Background:
- Single-chain T-cell receptors (scTCRs) are crucial for adaptive immunity.
- Existing scTCRs often lack the stability and expression efficiency required for therapeutic applications.
- Improving scTCR stability and solubility is key for developing novel immunotherapies.
Purpose of the Study:
- To engineer a highly stable and soluble single-chain T-cell receptor (scTCR) scaffold.
- To investigate the correlation between thermal stability and intracellular processing efficiency.
- To create a versatile scTCR scaffold for therapeutic applications and advanced selection strategies.
Main Methods:
- Directed evolution and yeast surface display were employed to enhance scTCR properties.
- scTCRs were evolved for thermal denaturation resistance and improved intracellular processing.
- Mutations were recombined to generate a superior scTCR scaffold.
Main Results:
- An engineered scTCR scaffold demonstrated high stability (over 1 hour at 65°C) and solubility (>4 mg/mL).
- Expression levels reached 7.5 mg/L in shake flasks, comparable to single-chain antibodies.
- The scaffold retained specific ligand binding to peptide-major histocompatibility complexes (pMHCs) and bacterial superantigen.
- Yeast displaying the scTCR formed conjugates with antigen-presenting cells (APCs).
Conclusions:
- Thermal stability is a reliable predictor of scTCR kinetic processing efficiency.
- The developed scTCR scaffold offers significant improvements over existing constructs.
- This scaffold enables engineering of high-affinity soluble scTCRs for antagonizing cell-mediated immunity.
- Novel in situ cell-to-cell selection strategies for scTCR evolution are feasible using APC conjugation.